SPG11 Chromosome 15
SPG11 vesicle trafficking associated, spatacsin
Upload your DNA to see your personal genotypes for variants in SPG11.
What This Gene Does
The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
Associated Conditions (41)
Autism spectrum disorder
Hereditary spastic paraplegia 11
Amyotrophic lateral sclerosis type 5
Charcot-Marie-Tooth disease axonal type 2X
Spastic paraparesis
Gait disturbance
Generalized hyperreflexia
Difficulty walking
Amyotrophic lateral sclerosis
Hereditary spastic paraplegia
Malignant tumor of esophagus
Nonpapillary renal cell carcinoma
Melanoma
Hepatocellular carcinoma
Thyroid cancer
nonmedullary
1
Acute myeloid leukemia
Clear cell carcinoma of kidney
Gastric cancer
+21 more conditions
Key Variants
RS2082749902
association
Autism spectrum disorder, Autism spectrum disorder
Health Risk
RS1040633382
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Charcot-Marie-Tooth disease axonal type 2X
Health Risk
RS1057518874
Conflicting classifications of pathogenicity
Spastic paraparesis, Gait disturbance, Generalized hyperreflexia
Health Risk
RS111347025
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis, Hereditary spastic paraplegia
Health Risk
RS114945876
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, Inborn genetic diseases, Hereditary spastic paraplegia 11
Health Risk
RS117683234
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, SPG11-related disorder, Hereditary spastic paraplegia 11
Health Risk
RS1256036525
Conflicting classifications of pathogenicity
Inborn genetic diseases, Hereditary spastic paraplegia 11, Inborn genetic diseases
Health Risk
RS1322622893
Conflicting classifications of pathogenicity
Inborn genetic diseases, Hereditary spastic paraplegia 11, Inborn genetic diseases
Health Risk
RS1331589550
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, Inborn genetic diseases, Hereditary spastic paraplegia 11
Health Risk
RS1352070054
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11
Health Risk
RS1360895808
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11
Health Risk
RS1379359957
Conflicting classifications of pathogenicity
Charcot-Marie-Tooth disease axonal type 2X, Hereditary spastic paraplegia 11, Inborn genetic diseases
Health Risk
All Variants (595)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS312262717 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262719 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X, Amyotrophic lateral sclerosis type 5 |
| RS312262720 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Hereditary spastic paraplegia |
| RS312262721 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262722 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, SPG11-related disorder |
| RS312262725 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262727 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262728 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262730 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262735 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262738 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262739 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Hereditary spastic paraplegia 11 |
| RS312262743 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262744 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262745 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia, Hereditary spastic paraplegia 11 |
| RS312262747 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia, Amyotrophic lateral sclerosis type 5 |
| RS312262749 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262750 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262752 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, SPG11-related disorder |
| RS312262753 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X, Hereditary spastic paraplegia 11 |
| RS312262755 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Spastic paraplegia, Inborn genetic diseases |
| RS312262757 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262759 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262762 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262763 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, Hereditary spastic paraplegia 11 |
| RS312262764 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, Hereditary spastic paraplegia |
| RS312262765 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262766 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262767 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, SPG11-related disorder, Hereditary spastic paraplegia 11 |
| RS312262769 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262770 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, Hereditary spastic paraplegia |
| RS312262775 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262777 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262778 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262779 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262782 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2X |
| RS312262784 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Inborn genetic diseases, Hereditary spastic paraplegia |
| RS312262785 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia, Inborn genetic diseases |
| RS312262788 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5, Hereditary spastic paraplegia 11 |
| RS368276916 | Health Risk | Pathogenic | Amyotrophic lateral sclerosis type 5, Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS369467143 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, SPG11-related disorder, Hereditary spastic paraplegia 11 |
| RS370252831 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS370259531 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS570599267 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X, Amyotrophic lateral sclerosis type 5 |
| RS587777921 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X, Amyotrophic lateral sclerosis type 5 |
| RS746329317 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS749652788 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia, Hereditary spastic paraplegia 11 |
| RS749705821 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS750101275 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X, Amyotrophic lateral sclerosis type 5 |
| RS750663981 | Health Risk | Pathogenic | Hereditary spastic paraplegia 11, Hereditary spastic paraplegia, Amyotrophic lateral sclerosis type 5 |